Acumen Pharmaceuticals, Inc. · NASDAQ:ABOS
Sands Capital Alternatives, LLC reported a 5.60% stake in Acumen Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 13, 2025
Sands Capital Alternatives, LLC reported a 5.60% stake in Acumen Pharmaceuticals, Inc., 3,417,075 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G/A).
- Stake
- 5.60%
- Shares
- 3,417,075
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sands Capital Alternatives, LLC | 5.60% | 3,417,075 |
| Sands Capital Ventures Discovery Fund III, L.P. | 1.90% | 1,124,729 |
| Sands Capital Global Venture Fund II, L.P. | 1.90% | 1,146,173 |
| Sands Capital Life Sciences Pulse Fund, LLC | 1.90% | 1,146,173 |
| SANDS FRANK M. | 5.60% | 3,417,075 |
Source
Related
- Acumen Pharmaceuticals, Inc.
- Sands Capital Alternatives, LLC
- Acumen Pharmaceuticals, Inc. shareholders
- Form 4 · Porter Derrell · Jun 17, 2026
- Form 4 · Fountain Nathan B · Jun 10, 2026
- Form 4 · RA Capital Nexus Fund II, L.P. · Jun 5, 2026
- Form 4 · Fountain Nathan B · Jun 5, 2026
- Form 4 · Drapkin Kimberlee C · Jun 5, 2026